Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines
Eguchi, T., Itadani, H., Shimomura, T., Kawanishi, N., Hirai, H., Kotani, H.Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-08-1159
Date:
June, 2009
File:
PDF, 830 KB
english, 2009